These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29057328)

  • 21. The role of individual susceptibility in cancer burden related to environmental exposure.
    Bartsch H; Hietanen E
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen.
    Perlow RA; Broyde S
    J Mol Biol; 2001 Jun; 309(2):519-36. PubMed ID: 11371169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen.
    Friedenson B
    Med Hypotheses; 2011 Nov; 77(5):791-7. PubMed ID: 21839586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems.
    Loechler EL
    Carcinogenesis; 1996 May; 17(5):895-902. PubMed ID: 8640935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
    Miller JA; Miller EC
    Br J Cancer; 1983 Jul; 48(1):1-15. PubMed ID: 6191767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA modification by chemical carcinogens.
    Jeffrey AM
    Pharmacol Ther; 1985; 28(2):237-72. PubMed ID: 3936066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of adducts formed in a shuttle vector by reactive metabolites of 1-nitropyrene and benzo(a)pyrene to induce mutations when the plasmid replicates in human cells.
    Maher VM; Yang JL; McCormick JJ
    Acta Biol Hung; 1990; 41(1-3):173-86. PubMed ID: 2128787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic and mutagenic effects of specific carcinogen-DNA adducts in diploid human fibroblasts.
    McCormick JJ; Maher VM
    Environ Health Perspect; 1985 Oct; 62():145-55. PubMed ID: 4085419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
    Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
    Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for cancer.
    Lyman GH
    Prim Care; 1992 Sep; 19(3):465-79. PubMed ID: 1410059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/5: mutagenesis in mammalian cells.
    Howard-Flanders P
    Mutat Res; 1981 May; 86(3):307-27. PubMed ID: 7029263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 2. Diet, mutation and cancer.
    Clayson DB
    Mutat Res; 1985 Nov; 154(3):205-17. PubMed ID: 3900715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adduct-induced base-shifts: a mechanism by which the adducts of bulky carcinogens might induce mutations.
    Loechler EL
    Biopolymers; 1989 May; 28(5):909-27. PubMed ID: 2742984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens.
    Seo KY; Jelinsky SA; Loechler EL
    Mutat Res; 2000 Oct; 463(3):215-46. PubMed ID: 11018743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrition and Cancer: An Historical Perspective.-The Past, Present, and Future of Nutrition and Cancer. Part 2. Misunderstanding and Ignoring Nutrition.
    Campbell TC
    Nutr Cancer; 2017; 69(6):962-968. PubMed ID: 28742399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NITROSOGENESIS OF SKIN (HUMAN) CANCER- THE HIDDEN TRUTH OF A NEVERENDING STORY: NITROSAMINE CONTAMINATION IN OLMESARTAN, VALSARTAN AND HCT AS MAIN RISK FACTOR FOR THE DEVELOPMENT OF KERATINOCYTE CANCER.
    Tchernev G; Kordeva S
    Georgian Med News; 2023 Apr; (337):63-67. PubMed ID: 37354675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conundrum in molecular toxicology: molecular and biological changes during neoplastic transformation of human cells.
    Milo GE; Shuler CF; Lee H; Casto BC
    Cell Biol Toxicol; 1995 Dec; 11(6):329-45. PubMed ID: 8788209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.